These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 7402444)

  • 21. Circling behavior following systemic d-amphetamine administration: potential noradrenergic and dopaminergic involvement.
    Kokkinidis L; Anisman H
    Psychopharmacology (Berl); 1979 Jun; 64(1):45-54. PubMed ID: 113831
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The relationship between cholinergic and dopaminergic mechanisms in the nucleus accumbens for the control of locomotor activity [proceedings].
    Costall B; Hui SC; Naylor RJ
    Br J Pharmacol; 1979 May; 66(1):121P-122P. PubMed ID: 454917
    [No Abstract]   [Full Text] [Related]  

  • 23. The interaction between beta-phenylethylamine and agents which affect the cholinergic nervous system on locomotor activity and toxicity in mice.
    Jackson DM
    Arzneimittelforschung; 1974 Jan; 24(1):24-7. PubMed ID: 4406104
    [No Abstract]   [Full Text] [Related]  

  • 24. The effect of manipulation of cholinergic mechanisms on turning behaviour in mice with unilateral destruction of the nigro-neostriatal dopaminergic system.
    Pycock C; Milson J; Tarsy D; Marsden CD
    Neuropharmacology; 1978 Mar; 17(3):175-83. PubMed ID: 565479
    [No Abstract]   [Full Text] [Related]  

  • 25. The role of the medial prefrontal cortex of rats in short-term memory functioning: further support for involvement of cholinergic, rather than dopaminergic mechanisms.
    Broersen LM; Heinsbroek RP; de Bruin JP; Uylings HB; Olivier B
    Brain Res; 1995 Mar; 674(2):221-9. PubMed ID: 7796100
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of adrenergic, cholinergic and dopaminergic involvement in the inhibition of hyperreactivity and interanimal aggression by the medial hypothalamus in the rat.
    Albert DJ; Wong RC; Brayley KN; Fibiger HC
    Pharmacol Biochem Behav; 1979 Jul; 11(1):1-10. PubMed ID: 573902
    [No Abstract]   [Full Text] [Related]  

  • 27. Reversal of early phenobarbital-induced cholinergic and related behavioral deficits by neuronal grafting.
    Rogel-Fuchs Y; Zahalka EA; Yanai J
    Brain Res Bull; 1994; 33(3):273-9. PubMed ID: 8293312
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The relative importance of dopaminergic and noradrenergic neuronal systems for the stimulation of locomotor activity induced by amphetamine and other drugs.
    Thornburg JE; Moore KE
    Neuropharmacology; 1973 Sep; 12(9):853-66. PubMed ID: 4147726
    [No Abstract]   [Full Text] [Related]  

  • 29. Studies related to the cholinergic influence on the accumulation and disappearance of monoamines in rat brain.
    Bhatnagar SP
    Can J Physiol Pharmacol; 1973 Dec; 51(12):893-9. PubMed ID: 4777240
    [No Abstract]   [Full Text] [Related]  

  • 30. Differential effects of striatal injections of dopaminergic, cholinergic and GABAergic drugs upon swimming behavior of rats.
    Vrijmoed-de Vries MC; Cools AR
    Brain Res; 1986 Jan; 364(1):77-90. PubMed ID: 3004649
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Interelationships between dopaminergic and cholinergic systems in the cerebral cortex.
    Mantovani P; Bartolini A; Pepeu G
    Adv Biochem Psychopharmacol; 1977; 16():423-7. PubMed ID: 883550
    [No Abstract]   [Full Text] [Related]  

  • 32. The effects of dopaminergic agents on the locomotor activity of rats after high doses of methylamphetamine.
    Lucot JB; Wagner GC; Schuster CR; Seiden LS
    Pharmacol Biochem Behav; 1980 Sep; 13(3):409-13. PubMed ID: 7422696
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cataleptic action of nitrazepam and brain dopamine function in mice.
    Matsui Y; Deguchi T
    Neuropharmacology; 1977 Apr; 16(4):253-8. PubMed ID: 140329
    [No Abstract]   [Full Text] [Related]  

  • 34. Cholinergic modulation of oral activity in drug-naive and chronic haloperidol-treated rats.
    See RE; Chapman MA
    Pharmacol Biochem Behav; 1991 May; 39(1):49-54. PubMed ID: 1924511
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cholinergic-dopaminergic interactions in experimental catalepsy.
    Klemm WR
    Psychopharmacology (Berl); 1983; 81(1):24-7. PubMed ID: 6415727
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evidence for a direct cholinergic involvement in the scopolamine-induced amnesia in monkeys: effects of concurrent administration of physostigmine and methylphenidate with scopolamine.
    Bartus RT
    Pharmacol Biochem Behav; 1978 Dec; 9(6):833-6. PubMed ID: 106402
    [No Abstract]   [Full Text] [Related]  

  • 37. Pharmacological interactions with circling behaviour induced by the piperidinyl indole derivative RU 23686.
    Boissier JR; Oberlander C; Dumont C; Peterfalvi M
    Psychopharmacology (Berl); 1977 Nov; 55(1):53-60. PubMed ID: 23562
    [No Abstract]   [Full Text] [Related]  

  • 38. GABAergic, dopaminergic and cholinergic interaction in tremorine-induced tremors in mice.
    Shukla VK; Garg SK; Kulkarni SK
    Methods Find Exp Clin Pharmacol; 1988 Jan; 10(1):27-31. PubMed ID: 2895827
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The relative importance of dopamine and noradrenaline receptor stimulation for the restoration of motor activity in reserpine or alpha-methyl-p-tyrosine pre-treated mice.
    Dolphin AC; Jenner P; Marsden CD
    Pharmacol Biochem Behav; 1976 Jun; 4(6):661-70. PubMed ID: 981283
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Role of cholinergic neurotransmission in the amygdala on performances of passive avoidance learning in mice.
    Nomura Y; Nishiyama N; Saito H; Matsuki N
    Biol Pharm Bull; 1994 Apr; 17(4):490-4. PubMed ID: 8069254
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.